GlassScriptPhysician profile
Taja M Elder
NPI 1053894121
$2,802.67
in general payments reported to CMS, 2019-2025
18 companies · $799 in 2025
The $799 reported for 2025 was more than what 81% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $440 · 2022: $774 · 2023: $219 · 2024: $571 · 2025: $799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,589.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,589.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $768.03 | 2021-2025 | Synchromedii, Inceptiv, Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $740.37 | 2021-2025 | Relistor |
| Saluda Medical Americas, INC. | $339.10 | 2024-2025 | Evoke |
| Grt US Holding, INC. | $153.59 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $153.41 | 2021-2024 | |
| Boston Scientific Corporation | $128.68 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Collegium Pharmaceutical, INC. | $108.71 | 2023-2025 | Xtampza, Belbuca |
| Globus Medical, INC. | $89.22 | 2025 | Senza |
| Arbor Pharmaceuticals, INC. | $67.10 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $53.07 | 2024-2025 | |
| Avanos Medical | $49.70 | 2025 | Generator, Standard Rf Disposables |
| Nevro Corp. | $31.30 | 2024 | Senza |
| Amgen INC. | $29.24 | 2021 | |
| Redhill Biopharma INC. | $27.83 | 2021 | |
| Ani Pharmaceuticals, INC. | $17.99 | 2025 | Purified Cortrophin Gel |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $16.04 | 2021 | |
| Merck Sharp & Dohme LLC | $14.91 | 2022 | |
| Idorsia Pharmaceuticals US INC | $14.38 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taja Elder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.